Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $126.1 million.

  • Prestige Consumer Healthcare's Cost of Revenue fell 247.01% to $126.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $484.3 million, marking a year-over-year decrease of 351.58%. This contributed to the annual value of $503.3 million for FY2025, which is 47.71% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Cost of Revenue stood at $126.1 million for Q4 2025, which was down 247.01% from $122.5 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Cost of Revenue high stood at $132.1 million for Q1 2023, and its period low was $100.7 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $124.7 million (2023), whereas its average is $121.6 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Cost of Revenue soared by 1952.83% in 2021 and then tumbled by 984.23% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Cost of Revenue stood at $119.4 million in 2021, then grew by 4.78% to $125.1 million in 2022, then fell by 0.25% to $124.8 million in 2023, then increased by 3.58% to $129.3 million in 2024, then decreased by 2.47% to $126.1 million in 2025.
  • Its Cost of Revenue was $126.1 million in Q4 2025, compared to $122.5 million in Q3 2025 and $109.2 million in Q2 2025.